Abstract:BACKGROUND:Severe acute pancreatitis (SAP) can result in intestinal mucosal barrier (IMB) dysfunction. This study was undertaken to demonstrate the effect of IGF-I on the intestinal mucosal barrier in rats with SAP and its possible mechanisms. METHODS:Seventy-two male Wistar rats were randomly divided into three groups: a sham operation (SO group, n=24), a SAP group not treated with IGF-I (SAP group, n=24), and a SAP group treated with IGF-I (IGF-I group, n=24). SAP was induced in the rats by injecting 5.0% sodium taurocholate into the biliary-pancreatic duct. The SO rats were given an infusion of normal saline instead. The rats in the IGF-I group underwent the SAP procedure and were given a subcutaneous injection of IGF-I at 30 minutes before the operation and at 3 hours after the operation. Eight rats in each group were sacrificed at 6, 12 and 24 hours after operation. Apoptosis of mucosal cells in the small intestine was determined by TUNEL. The levels of endotoxin and DAO and serum amylase were also measured. Pathologic changes in the small intestine were monitored. Changes of bax and bcl-2 mRNA expression in the small intestine were determined by reverse transcription polymerase chain reaction (RT-PCR). RESULTS:The levels of serum amylase were lower in the IGF-I group than in the SAP group at all three time points (P<0.05). The levels of endotoxin in the IGF-I group were higher than those in the SAP group at 6 hours, but lower in the IGF-I group than in the SAP group at 12 and 24 hours (P<0.05). The levels of diamine oxidase were higher in the IGF-I group at 6 hours but lower than those in the SAP group at 12 and 24 hours. The pathological score of the small intestine was lower in the IGF-I group than in the SAP group, and the difference was statistically significant at 12 and 24 hours. The pathologic changes observed under electron microscopy were better in the IGF-I group than those in the SAP group. The apoptosis index of intestinal epithelial cells was significantly decreased in the IGF-I group compared with the SAP group. Compared with the SO group, the mRNA expression levels of bax were increased at each time point in the SAP group, and were significantly decreased in the IGF-I group as compared with the SAP group at each time point (P<0.05). The expression levels of bcl-2 were weak and not different between the SO group and the SAP group (P>0.05). They were significantly increased in the IGF-I group versus the SO and SAP groups (P<0.05). The ratio of bax and bcl-2 mRNA expression levels at each time point in the SAP group were significantly higher than those in the SO group, but they were obviously decreased in the IGF-I group. CONCLUSIONS:Exogenous IGF-I seems to protect mucosal cells in the small intestine against SAP-induced apoptosis and could alleviate SAP-induced injury of the intestinal mucosa. The underlying mechanisms include enhanced mRNA expression of bcl-2 and inhibition of bax mRNA expression.

Increased proportion of nitric oxide synthase immunoreactive neurons in rat ileal myenteric ganglia after severe acute pancreatitis

Emodin Alleviates Intestinal Mucosal Injury in Rats with Severe Acute Pancreatitis Via the Caspase-1 Inhibition.

Influence of NF-kappa B-Vasoactive Intestinal Peptide on Intestinal Dysmotility in Severe Acute Pancreatitis

Damage of the Interstitial Cells of Cajal and Myenteric Neurons Causing Ileus in Acute Necrotizing Pancreatitis Rats

Expression of 5-hydroxytryptamine and its receptor in severe acute pancreatitis rats with intestinal motility disorder

Effect of PYY on NO and iNOS in rats with severe acute pancreatitis

Role of Neurocrine Somatostatin on Sphincter of Oddi Contractility and Intestinal Ischemia Reperfusion-Induced Acute Pancreatitis in Macaques

Alterations of intestinal immune function and regulatory effects of L-arginine in rats with experimental severe acute pancreatitis

Effect of Octreotide on Enteric Motor Neurons in Experimental Acute Necrotizing Pancreatitis.

Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats with Severe Acute Pancreatitis.

Experimental Study on the Change of Intestinal Immune Function in Rats with Hyperlipidemia and Severe Acute Pancreatitis

Effect of Protease Activated Receptor-2 Agonist on Intestinal SIgA in Rats with Acute Necrotizing Pancreatitis

The Expression of Nuclear Factor-kappa B in Pancreatic Tissue of Rats with Severe Acute Pancreatitis

Dynamic Changes of the Colonic Microbiota in Rat during Severe Acute Pancreatitis

Effect of indomethacin on the splanchnic blood flow in rats with severe acute pancreatitis

Protective Effect of Exogenous IGF-I on the Intestinalmucosal Barrier in Rats with Severe Acute Pancreatitis.

Changes of Amount and Ultrastructure of Interstitial Cells of Cajal in Rats with Severe Acute Pancreatitis and Their Importance.

A Simple Taurocholate-Induced Model of Severe Acute Pancreatitis in Rats.

Changes of genome expression profile in pancreas of rats with severe acute pancreatitis

Effects of Gut Barrier Dysfunction and NF-kappaB Activation on Aggravating Mechanism of Severe Acute Pancreatitis.

Effect of PYY on severe acute pancreatitis in rats